Panacea Biotec Limited (BOM:531349)
India · Delayed Price · Currency is INR 363.80
+14.45 (4.14%)
At close: Oct 6, 2026
Panacea Biotec Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 22,246 | 18,133 | 27,027 | 7,445 | 6,643 | 9,077 | |
Market Cap Growth | -12.53% | -32.91% | 263.02% | 12.08% | -26.82% | -17.16% |
Enterprise Value | 21,679 | 17,035 | 25,428 | 5,776 | 3,942 | 15,905 |
Last Close Price | 363.80 | 296.15 | 440.65 | 121.30 | 108.35 | 148.25 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | - | - | 0.84 |
PS Ratio | 3.31 | 2.83 | 4.83 | 1.33 | 1.44 | 1.37 |
PB Ratio | 2.68 | 2.19 | 3.25 | 0.89 | 0.79 | 1.04 |
P/TBV Ratio | 2.84 | 2.37 | 3.48 | 0.94 | 0.82 | 1.08 |
P/OCF Ratio | 133.26 | 108.62 | - | 214.68 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 3.22 | 2.66 | 4.55 | 1.03 | 0.86 | 2.40 |
EV/EBITDA Ratio | - | 545.48 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.04 |
Debt / EBITDA Ratio | 8.18 | 7.05 | - | - | - | - |
Net Debt / Equity Ratio | -0.06 | -0.05 | -0.13 | -0.16 | -0.23 | -0.59 |
Net Debt / EBITDA Ratio | -17.55 | -14.28 | 5.16 | 17.91 | 3.01 | 91.95 |
Net Debt / FCF Ratio | - | 1.19 | 1.38 | 1.64 | 0.42 | 4.28 |
Asset Turnover | - | 0.50 | 0.44 | 0.45 | 0.30 | 0.45 |
Inventory Turnover | - | 1.38 | 1.02 | 1.21 | 1.22 | 1.36 |
Quick Ratio | - | 0.41 | 0.55 | 0.68 | 0.83 | 0.82 |
Current Ratio | - | 1.47 | 1.57 | 1.57 | 1.71 | 1.28 |
Return on Equity (ROE) | - | -0.86% | -1.04% | -0.18% | -3.94% | 335.95% |
Return on Assets (ROA) | - | -1.32% | -2.62% | -2.06% | -4.24% | -2.06% |
Return on Invested Capital (ROIC) | -3.89% | -3.58% | -7.40% | 6.24% | 53.96% | -6.64% |
Return on Capital Employed (ROCE) | - | -3.00% | -5.70% | -4.50% | -10.90% | -4.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -0.32% | -0.30% | -0.31% | -0.16% | -5.00% | 118.79% |
FCF Yield | -1.68% | -2.06% | -2.87% | -10.67% | -69.76% | -13.33% |